GlyCosmos Glycolipids
Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
| Database | Last Updated |
|---|---|
| ChEBI | February 3, 2022 |
| KEGG | February 3, 2022 |
| LIPID MAPS Structure Database | February 3, 2022 |
| LipidBank | February 3, 2022 |
| PubChem | February 3, 2022 |
| Main Class | Sub Class | LM ID | Common Name | LipidBank ID | KEGG ID | PubChem CID ▲ | ChEBI ID | Exact Mass | Formula |
|---|---|---|---|---|---|---|---|---|---|
|
Neutral glycosphingolipids
|
Simple Glc series (GlcCer, LacCer, etc.)
|
999.758594
|
C56H105NO13
|
||||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
Gb3(d18:1/16:0)
|
1023.670569
|
C52H97NO18
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
Gb3(d18:1/18:0)
|
1051.701869
|
C54H101NO18
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
Gb3(d18:1/20:0)
|
1079.733169
|
C56H105NO18
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
Gb3(d18:1/22:0)
|
1107.764469
|
C58H109NO18
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
Gb3(d18:1/24:0)
|
1135.795769
|
C60H113NO18
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
Gb3(d18:1/26:0)
|
1163.827069
|
C62H117NO18
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
Gb3(d18:1/24:1(15Z))
|
1133.780119
|
C60H111NO18
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
Gb3(d18:1/26:1(17Z))
|
1161.811419
|
C62H115NO18
|
|||||
|
Neutral glycosphingolipids
|
GalNAcb1-3Gala1-4Galb1-4Glc- (Globo series)
|
Globoside I/Cytolipin K(d18:1/16:0)
|
1226.749943
|
C60H110N2O23
|
Displaying entries 131 - 140 of 3908 in total
To see the latest features, please visit our beta site.
International Collaboration
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Acknowledgements
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
